Medical guidance. Informed decisions.
GLP-1–based medications may be considered for eligible patients as part of medical weight management. The specific product, indication, dosing, and follow-up must be determined by a qualified prescribing clinician.
Semaglutide, tirzepatide, and the names you see online
Semaglutide acts on GLP-1 pathways; tirzepatide acts on both GIP and GLP-1 pathways involved in appetite regulation. The exact product and approved use matter. A familiar medication name does not establish your eligibility, and a clinic package is not a prescription. Ask which specific product is proposed and why.
A care decision beyond a starting prescription
Discuss how a recommendation would fit your existing medicines, nutrition and activity needs, previous treatment, and personal circumstances. Ask how the plan would be reviewed, how concerns would be handled, and what happens if tolerability, cost, or supply becomes a problem. Those practical details belong in the initial conversation.
What a complete quote should explain
Ask whether assessment, any clinically indicated testing, medication, supplies, and follow-up are included or separate. Clarify cancellation and ongoing payment terms. Hyperwell has not published a fee schedule or confirmed particular products; a consultation should make the actual proposal and its costs clear before you decide.
Independent background: NIDDK: prescription weight-management medications ↗
Make the first conversation useful
A little preparation. A clearer next step.
Bring your goals, current medication list, and any relevant previous records. You do not need to choose a medication in advance.
Your consultation questions ↗What to discuss at your visit
- Review your health history, medications, pregnancy plans, and treatment goals.
- Discuss the selected medication’s labeling, contraindications, side effects, and alternatives.
- Plan prescribing, monitoring, and follow-up only if treatment is clinically appropriate.
Suitability & safety
Nausea, vomiting, diarrhea, constipation, and other adverse effects can occur. Serious risks and contraindications vary by product; review the complete prescribing information with your clinician. Compounded drugs are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. No particular medication or prescription is guaranteed.
Common questions
Will I qualify for treatment?
Eligibility depends on the medication’s approved indication, your history, and the prescriber’s assessment. An appointment does not guarantee a prescription.
Which medication will I receive?
A medication is selected only after clinical evaluation. This website does not promise a specific brand, formulation, supply, or dose.
